Vallabhaneni S R, Björses K, Malina M, Dias N V, Sonesson B, Ivancev K
Endovascular Centre, Malmö University Hospital, 205 02 Malmö, Sweden.
Eur J Vasc Endovasc Surg. 2005 Sep;30(3):307-10. doi: 10.1016/j.ejvs.2005.04.043.
To examine the safety and efficacy of endovascular management of isolated infrarenal aortic occlusive disease within our centre.
Retrospective analysis of all patients who underwent endovascular treatment of occlusive disease that is confined to the infrarenal aorta between September 1993 and November 2004.
Primary aortic stenting was carried out in 16 women and five men using self-expanding (12 patients) and balloon expanding stents to treat both occlusions (six) and stenoses (15). Indications included intermittent claudication (13), critical limb ischaemia (six), and distal embolisation (three). Significant postoperative complications within 30 days were noted in three, including one death. Fifteen patients completed 1-year follow-up with primary patency in 14 and secondary patency in the remaining patient. Clinical improvement was documented in all patients.
Primary stenting for occlusive disease isolated in the infrarenal aorta is relatively safe in selected patients with encouraging early follow-up results.
在我们中心探讨腔内治疗孤立性肾下腹主动脉闭塞性疾病的安全性和有效性。
回顾性分析1993年9月至2004年11月期间所有接受局限于肾下腹主动脉闭塞性疾病腔内治疗的患者。
16名女性和5名男性接受了原发性主动脉支架置入术，使用自膨式支架（12例患者）和球囊扩张式支架治疗闭塞（6例）和狭窄（15例）。适应证包括间歇性跛行（13例）、严重肢体缺血（6例）和远端栓塞（3例）。30天内出现显著术后并发症的有3例，包括1例死亡。15例患者完成了1年随访，14例患者实现了原发性通畅，其余1例患者实现了继发性通畅。所有患者均有临床改善记录。
对于选定的患者，肾下腹主动脉孤立性闭塞性疾病的原发性支架置入术相对安全，早期随访结果令人鼓舞。
